Cargando…

Determination of risk factors for drug-related problems: a multidisciplinary triangulation process

INTRODUCTION AND OBJECTIVES: Drug-related problems (DRPs) constitute a frequent safety issue among hospitalised patients leading to patient harm and increased healthcare costs. Because many DRPs are preventable, the specific risk factors that facilitate their occurrence are of considerable interest....

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaufmann, Carole P, Stämpfli, Dominik, Hersberger, Kurt E, Lampert, Markus L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Pharmacology and Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368979/ https://www.ncbi.nlm.nih.gov/pubmed/25795686 http://dx.doi.org/10.1136/bmjopen-2014-006376

Ejemplares similares

Drug-Associated Risk Tool: development and validation of a self-assessment questionnaire to screen for hospitalised patients at risk for drug-related problems
por: Kaufmann, Carole P, et al.
Publicado: (2018)

Assessing the ability of the Drug-Associated Risk Tool (DART) questionnaire to stratify hospitalised older patients according to their risk of drug-related problems: a cross-sectional validation study
por: Stämpfli, Dominik, et al.
Publicado: (2018)

Health Canada's use of its priority review process for new drugs: a cohort study
por: Lexchin, Joel
Publicado: (2015)

Process of drug registration in Israel: the correlation between the number of discussions within the Ministry of Health and postapproval variations by EMA and/or FDA
por: Hiayev, Stephany, et al.
Publicado: (2023)

Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study
por: Wolff, Jan, et al.
Publicado: (2021)

Clarity and applicability of adverse drug reaction-related monitoring instructions in clinical practice guidelines for children and adolescents treated with antipsychotic drugs: a review of six clinical practice guidelines
por: Minjon, Lenneke, et al.
Publicado: (2022)

Nurse-led medicines’ monitoring in care homes study protocol: a process evaluation of the impact and sustainability of the adverse drug reaction (ADRe) profile for mental health medicines
por: Jordan, Sue, et al.
Publicado: (2018)

A prospective study of adverse drug reactions to antiepileptic drugs in children
por: Anderson, Mark, et al.
Publicado: (2015)

Evaluation of the Prevalence and Risk Factors of Drug-Related Problems in Hypertension and Type 2 Diabetes Mellitus Patients at a Tertiary Care Hospital: A Cross-Sectional Study
por: Reddy Peddi, Divya, et al.
Publicado: (2023)

Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients
por: Kiguba, Ronald, et al.
Publicado: (2017)

Non-steroidal anti-inflammatory drug (NSAID) related inhibition of aldosterone glucuronidation and arterial dysfunction in patients with rheumatoid arthritis: a cross-sectional clinical study
por: Crilly, Michael A, et al.
Publicado: (2011)

Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden
por: Loikas, Desirée, et al.
Publicado: (2013)

Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study
por: Sharma, Megha, et al.
Publicado: (2021)

How innovative are new drugs launched in the UK? A retrospective study of new drugs listed in the British National Formulary (BNF) 2001–2012
por: Ward, Derek J, et al.
Publicado: (2014)

Antidopaminergic drugs and acute pancreatitis: a population-based study
por: Bodén, Robert, et al.
Publicado: (2012)

Changes in drug disposition of lithium during pregnancy: a retrospective observational study of patient data from two routine therapeutic drug monitoring services in Norway
por: Westin, Andreas Austgulen, et al.
Publicado: (2017)

Assessment of drug use pattern using WHO core drug use indicators in selected general hospitals: a cross-sectional study in Tigray region, Ethiopia
por: Tassew, Segen Gebremeskel, et al.
Publicado: (2021)

Drug–drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case–control study in the National COVID Cohort Collaborative (N3C)
por: Kravchenko, Olga V, et al.
Publicado: (2022)

Global prevalence of antidepressant drug utilization in the community: protocol for a systematic review
por: Lunghi, Carlotta, et al.
Publicado: (2022)

Process mapping evaluation of medication reconciliation in academic teaching hospitals: a critical step in quality improvement
por: Holbrook, Anne, et al.
Publicado: (2016)

Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions
por: Fleet, Jamie L, et al.
Publicado: (2013)

Off-label drug prescriptions in French general practice: a cross-sectional study
por: Drogou, François, et al.
Publicado: (2019)

The impact of pharmacist-led medication reconciliation and interprofessional ward rounds on drug-related problems at hospital discharge
por: Studer, Helene, et al.
Publicado: (2022)

Hepatitis C virus screening in community pharmacies: results on feasibility from a Swiss pilot
por: Stämpfli, Dominik, et al.
Publicado: (2023)

How are drug regimen changes during hospitalisation handled after discharge: a cohort study
por: Viktil, Kirsten K, et al.
Publicado: (2012)

Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions
por: Osanlou, Rostam, et al.
Publicado: (2022)

Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL)
por: Hjelmesæth, Jøran, et al.
Publicado: (2018)

Behaviour change interventions to promote prescribing of generic drugs: a rapid evidence synthesis and systematic review
por: Moe-Byrne, Thirimon, et al.
Publicado: (2014)

Trends in clinical development timeframes for antiviral drugs launched in the UK, 1981–2014: a retrospective observational study
por: Ward, Derek J, et al.
Publicado: (2015)

Healthcare professionals knowledge, attitude and practice of adverse drug reactions reporting in Ethiopia: a cross-sectional study
por: Gidey, Kidu, et al.
Publicado: (2020)

Drug exposure during pregnancy in primary care: an algorithm and observational study from SIDIAP database, Catalunya, Spain
por: Lestón Vázquez, Marta, et al.
Publicado: (2023)

Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study
por: Reis, Margareta, et al.
Publicado: (2013)

Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study
por: Sadowski, Alexander, et al.
Publicado: (2013)

Evaluation of exposure to effervescent drugs in a large health check-up population in France: a cross-sectional study
por: Perrin, Germain, et al.
Publicado: (2018)

Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study
por: Zeitoun, Jean-David, et al.
Publicado: (2017)

Trends of prescribing antimicrobial drugs for urinary tract infections in primary care in the Netherlands: a population-based cohort study
por: Mulder, Marlies, et al.
Publicado: (2019)

Clinical and economic impact of adverse drug reactions in hospitalised patients: prospective matched nested case–control study in Ethiopia
por: Sendekie, Ashenafi Kibret, et al.
Publicado: (2023)

The association between patients’ beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire survey
por: Sjölander, Maria, et al.
Publicado: (2013)

Failures to further developing orphan medicinal products after designation granted in Europe: an analysis of marketing authorisation failures and abandoned drugs
por: Giannuzzi, Viviana, et al.
Publicado: (2017)

Utilisation, expenditure and cost-effectiveness of cystic fibrosis drugs in Ireland: a retrospective analysis of a national pharmacy claims database
por: Smith, Amelia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_knpcbf4om8rmi7q4oup7re90u7